Clearside Biomedical Files 2024 10-K
Ticker: CLSDQ · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1539029
| Field | Detail |
|---|---|
| Company | Clearside Biomedical, Inc. (CLSDQ) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Clearside Biomedical filed its 2024 10-K. All the deets are in there.
AI Summary
Clearside Biomedical, Inc. filed its 2024 10-K on March 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on pharmaceutical preparations, is incorporated in Delaware and headquartered in Alpharetta, Georgia. Key financial details and operational highlights for the fiscal year are detailed within the report.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Clearside Biomedical's financial performance and strategic positioning for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Clearside Biomedical faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the 10-K report.)
- 2025-03-27 — Filing Date (The date the 10-K was submitted to the SEC.)
Key Players & Entities
- Clearside Biomedical, Inc. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end date
- 2025-03-27 (date) — Filing date of the 10-K
- Alpharetta, GA (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- Cantor Fitzgerald & Co. (company) — Mentioned in relation to a Sales Agreement
FAQ
What is the primary business of Clearside Biomedical, Inc.?
Clearside Biomedical, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code 2834.
When did Clearside Biomedical, Inc. file its 10-K report for the fiscal year 2024?
The 10-K report for the fiscal year ending December 31, 2024, was filed on March 27, 2025.
Where is Clearside Biomedical, Inc. headquartered?
Clearside Biomedical, Inc. is headquartered in Alpharetta, GA.
What is the SEC file number for Clearside Biomedical, Inc.'s 10-K filing?
The SEC file number for this 10-K filing is 001-37783.
What is the state of incorporation for Clearside Biomedical, Inc.?
Clearside Biomedical, Inc. is incorporated in Delaware (DE).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding Clearside Biomedical, Inc. (CLSDQ).